Clinical applications of MS-based protein quantification

Proteomics Clin Appl. 2016 Apr;10(4):323-45. doi: 10.1002/prca.201500116. Epub 2016 Mar 11.

Abstract

Mass spectrometry-based assays are increasingly important in clinical laboratory medicine and nowadays are already commonly used in several areas of routine diagnostics. These include therapeutic drug monitoring, toxicology, endocrinology, pediatrics, and microbiology. Accordingly, some of the most common analyses are therapeutic drug monitoring of immunosuppressants, vitamin D, steroids, newborn screening, and bacterial identification. However, MS-based quantification of peptides and proteins for routine diagnostic use is rather rare up to now despite excellent analytical specificity and good sensitivity. Here, we want to give an overview over current fit-for-purpose assays for MS-based protein quantification. Advantages as well as challenges of this approach will be discussed with focus on feasibility for routine diagnostic use.

Keywords: Mass spectrometry; Protein quantification.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / blood
  • Blood Proteins / analysis*
  • Chromatography, Liquid
  • Drug Monitoring / instrumentation
  • Drug Monitoring / methods*
  • Humans
  • Immunosuppressive Agents / blood
  • Infant, Newborn
  • Mass Spectrometry
  • Medical Laboratory Science / instrumentation
  • Medical Laboratory Science / methods*
  • Neonatal Screening
  • Peptide Hormones / blood
  • Proteomics / instrumentation
  • Proteomics / methods*
  • Quality Control
  • Vitamin D / blood

Substances

  • Biomarkers, Tumor
  • Blood Proteins
  • Immunosuppressive Agents
  • Peptide Hormones
  • Vitamin D